Financial Performance - Q3 2024 revenue reached $7.42 million, an 18.7% increase from Q2 2024 and a 111% increase compared to Q3 2023, driven by growth in the B2B2C business [4][13] - Q3 operating loss decreased by 25.7% sequentially to $12 million on a GAAP basis and by 33.3% to $7.1 million on a non-GAAP basis [1][7] - Gross profit for Q3 2024 was $3.9 million, a 534% increase compared to Q3 2023, with gross margins reaching 52.2% [15] - Pro-forma gross profit for Q3 2024 was $5.2 million, or 70.3% of revenues, excluding $1.34 million of amortization expenses [16] Business Momentum and Strategic Wins - Secured 10 new B2B2C clients, including a national Medicare advantage health plan, a regional Medicaid health plan, and a global leading pharma company [1][9] - Transformed the pharma/medical device channel into a recurring revenue model, securing two new deals, including one with a top six global pharma company [1][10] - Completed the integration of Twill's capabilities, creating a comprehensive digital health solution under the Dario brand [11] Cost Management and Synergies - Implemented cost-management strategies post-Twill acquisition, reducing GAAP operating expenses by 16% sequentially to $15.9 million and non-GAAP operating expenses by 15.9% to $12.3 million [6] - Expected to reduce operating expenses by 38% by Q1 2025 compared to Q1 2024, contributing to a 49% reduction in operating losses and a 59% reduction in non-GAAP operating losses [1][8] Future Outlook - On track to achieve operational cash flow breakeven run rate by the end of 2025 [1][8] - Anticipates continued revenue growth and increasing gross margins due to positive mix shift and reduced fixed expenses [8] Industry and Market Position - DarioHealth is a leader in the global digital health market, offering a multi-chronic condition digital therapeutics platform [2][29] - The company's AI capabilities, including generative AI and microservices, are expected to revolutionize areas like drug discovery and consumer engagement [12]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 | --- | --- | |------------------------------------------------------------------------------------------- ...

The new contract marks the eighth health plan for Dario and will contribute to revenues starting immediately. NEW YORK, Oct. 30, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract with a regional health plan in the Medicaid space, which has launched with the full suite of cardiometabolic solutions. The launch with this new health plan marks the third Medicaid client for Dario, continuing a solid momen ...

Company to host conference call and webcast at 8:30am ETNEW YORK, Oct. 23, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a global leader in digital health, announced today that it will release its financial results for the 3rd quarter ended September 30th, 2024 and will host a conference call and webcast at 8:30 am Eastern Time, on Thursday, November 7th, 2024, before the market opens.Erez Raphael, Chief Executive Officer, and Steven Nelson, Chief Commercial Officer, will ...

Integration of behavioral health and wellbeing solutions with navigation and engagement technology creates the most comprehensive solution in the market under the Dario brand NEW YORK, Oct. 17, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a global leader in digital health, today announces the full integration of Twill's advanced behavioral health and navigation capabilities into the Dario platform. The integration completes Dario's effort to create one of the most compre ...

New offer gives Dario access to millions of AARP members, enabling engagement with people over 50 in health and well-being beginning in January 2025 NEW YORK, Oct. 15, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new AARP member benefit that provides members with proven digital behavioral health and well-being solutions from Twill by Dario. The new benefit is expected to launch in January of 2025 for AARP me ...

DarioHealth Corp. (DRIO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices - - has triggered this rating change. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system. ...

The Dow Jones index closed higher by more than 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Red Robin The Trade: Red Robin Gourmet Burgers, Inc. RRGB Presi ...

The integration of Twill's condition-specific, expert-led peer groups will enhance the member experience and deepen engagement with Dario's proven cardiometabolic solution NEW YORK, Sept. 12, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market announced today the integration of condition-specific communities and peer groups with personalized navigation capabilities into its cardiometabolic solution to improve outcomes-based engagemen ...

New Research Confirms the Benefit of Dario's Integrated, Data-Driven Approach to Health and Chronic Condition Management NEW YORK, Sept. 10, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market announced today the publication of a new study in the peer-reviewed journal Frontiers in Endocrinology. The study demonstrates the effectiveness of Dario's cardiometabolic solution for members living with diabetes or prediabetes and depression. ...